Loading...
XNAS
ZTEK
Market cap76mUSD
Dec 04, Last price  
0.76USD
1D
0.69%
1Q
-8.48%
Jan 2017
18.45%
IPO
133.96%
Name

Zentek Ltd

Chart & Performance

D1W1MN
XNAS:ZTEK chart
P/E
P/S
122.96
EPS
Div Yield, %
Shrs. gr., 5y
6.02%
Rev. gr., 5y
%
Revenues
872k
+2,826.26%
000000000002,355339,66672,85529,816872,495
Net income
-10m
L-14.22%
-147,951-1,242,022-1,039,298-2,351,960-3,524,807-3,015,706-4,197,806-2,840,621-1,564,521-2,428,153-1,534,348-3,868,650-38,694,048-14,414,266-11,703,990-10,039,658
CFO
-6m
L-21.97%
-37,741-1,084,560-1,317,792-1,640,185-2,385,803-1,246,360-1,681,810-1,710,072-999,855-1,183,545-1,356,386-1,794,683-7,988,872-12,956,870-8,051,589-6,282,441

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
IPO date
Dec 22, 2010
Employees
29
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT